Search research articles
Contact Us
Filters
Showing results (201-210 of 265) with videos related to
Page
of 27
Sort By:
Oncogene
|
January 7, 1998
TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis
J M de Anta, E Jassem, R Rosell, et al.
Psychopharmacology
|
May 1, 2014
Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112
Judy L Thompson, Daniel R Rosell, Mark Slifstein, et al.
Schizophrenia Research
|
April 12, 2024
The MATRICS consensus cognitive battery for the assessment of cognitive impairment in schizotypal personality disorder
Katelyn N Challman, Daniel R Rosell, Deanna Barch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer
D Isla, R Rosell, J J Sánchez, et al.
The American Journal of Psychiatry
|
January 19, 2019
Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder
Margaret M McClure, Fiona Graff, Joseph Triebwasser, et al.
British Journal of Cancer
|
March 26, 2008
ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen
J Wei, Z Zou, X Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 1997
Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer
M Sánchez-Céspedes, R Rosell, A Pifarré, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2000
Altered HOX and WNT7A expression in human lung cancer
R Calvo, J West, W Franklin, et al.
British Journal of Cancer
|
May 10, 2014
Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer
J Wei, C Costa, J Shen, et al.
Revue Des Maladies Respiratoires
|
February 3, 2007
The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer
R Rosell, T Moran, M Fernanda Salazar, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 265) with videos related to
Sort By:
Page
of 27
Oncogene
|
January 7, 1998
TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis
J M de Anta, E Jassem, R Rosell, et al.
Psychopharmacology
|
May 1, 2014
Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112
Judy L Thompson, Daniel R Rosell, Mark Slifstein, et al.
Schizophrenia Research
|
April 12, 2024
The MATRICS consensus cognitive battery for the assessment of cognitive impairment in schizotypal personality disorder
Katelyn N Challman, Daniel R Rosell, Deanna Barch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer
D Isla, R Rosell, J J Sánchez, et al.
The American Journal of Psychiatry
|
January 19, 2019
Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder
Margaret M McClure, Fiona Graff, Joseph Triebwasser, et al.
British Journal of Cancer
|
March 26, 2008
ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen
J Wei, Z Zou, X Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 1997
Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer
M Sánchez-Céspedes, R Rosell, A Pifarré, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2000
Altered HOX and WNT7A expression in human lung cancer
R Calvo, J West, W Franklin, et al.
British Journal of Cancer
|
May 10, 2014
Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer
J Wei, C Costa, J Shen, et al.
Revue Des Maladies Respiratoires
|
February 3, 2007
The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer
R Rosell, T Moran, M Fernanda Salazar, et al.
Page
of 27